Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Cross-Sectional, Observational, Epidemiologic Study to Describe the Burden and the Related factors of Caregivers of Advanced Parkinson's Disease Patients Either Treated with Continuous Dopaminergic Delivery Systems (CSAI or LCIG) or Standard of Care Therapy (SOC)

Trial Profile

A Cross-Sectional, Observational, Epidemiologic Study to Describe the Burden and the Related factors of Caregivers of Advanced Parkinson's Disease Patients Either Treated with Continuous Dopaminergic Delivery Systems (CSAI or LCIG) or Standard of Care Therapy (SOC)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Levodopa/carbidopa (Primary) ; Apomorphine
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms PREDICT
  • Sponsors AbbVie
  • Most Recent Events

    • 09 Oct 2018 New trial record
    • 01 May 2018 Primary endpoint (Caregiver burden and its related factors among caregivers of APD patients using the Zarit Caregiver Burden Interview (ZBI) score:levodopa/carbidopa intestinal gel (LCIG) infusion versus continuous subcutaneous apomorphine infusion (CSAI) and continuation of standard of care (SOC)) has not been met, according to results published in the Journal of Neurology.
    • 01 May 2018 According to results published in the Journal of Neurology, patients were enrolled from Sept 2014 to Sept 2015.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top